Extended Treatment-Free Hospitalization-Free Time and Quality of Life Benefits with CAR T-cell Therapy in Subgroups of Patients with relapsed/refractory MM: Insights from the KarMMa-3 Trial

Transplantation and Cellular Therapy 2026

View at publisher

Authors: Krina K. Patel, Lin Wang, Rashmi Bhatnagar, Roland Marion‐Gallois, Martina Raggi, Sophie Hello, Paula Rodríguez‐Otero

DOI: 10.1016/j.jtct.2025.12.228

Cited by: 0

Fields of Study & Subjects

Multiple Myeloma Research and Treatments CAR-T cell therapy research Health Systems Economic Evaluations Quality of Life